Interviews /
by Anna Napoli -
5 years ago
30 Apr 2019 - Anatara Lifesciences Limited (ASX:ANR) CEO, Steven Lydeamore talks about the company's clinical studies program and its lead Gastrointestinal Reprogramming Product (G…
Company Presentations /
by -
5 years ago
30 Apr 2019 - Anatara Lifesciences Limited (ASX:ANR) CEO, Steven Lydeamore presents on the company's lead Gastrointestinal Reprogramming Product (GaRP) for Irritable Bowel Syndrome…
Interviews /
by Carolyn Herbert -
8 years ago
30 Jun 2016 - Anatara Lifesciences (ASX:ANR) Chairman, Dr Mel Bridges, discusses Detatch, a new natural treatment for scour and gastrointestinal disease.
Company News /
by David Chau -
8 years ago
23 Jun 2016 - Anatara Lifesciences Ltd (ASX:ANR) terminates third efficacy study in Australia for its lead product, Detach.
Company News /
by David Chau -
8 years ago
16 Jun 2016 - Anatara commences two new animal trials, and expects to launch its lead product, Detach, in 2017.
Market Reports /
by -
9 years ago
03 Jul 2015 - Aus shares follow Wall St lower. New Zealand based Orion Health Group Limited (ASX:OHE) secures two new strategic deals in Vietnam to build its market presence in Asi…
Interviews /
by -
10 years ago
03 Nov 2014 - Anatara Lifesciences (ASX:ANR) Chief Scientific Officer Tracey Mynott outlines the company’s strategy following its ASX debut.
